Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum , an Underrecognized Microorganism

Clinical Microbiology Reviews
S Corvec

Abstract

The recent description of the genus Cutibacterium has altered the taxonomy of Propionibacterium species. These organisms still belong to the genera of the skin coryneform group, and the most-studied species remains Cutibacterium acnes. Cutibacterium avidum is also a known skin commensal. This underrecognized microorganism can, however, act as a pathogen after bacterial seeding and can be considered opportunistic, causing either superficial or deep/invasive infections. It can cause numerous infections, including but not limited to breast infections, skin abscesses, infective endocarditis, and device-related infections. The ecological niche of C. avidum is clearly different from that of other members of the genus: it is found in the axillary region or at wet sites rather than in dry, exposed areas, and the number of microorganisms increases during puberty. Historically, it has been used for its ability to modulate the immune response and for its antitumor properties. Conventional microbial culture methods and identification processes allow for its accurate identification and characterization. Thanks to the modern omics tools used for phylogenomic approaches, understanding C. avidum pathogenesis (including host-bacterium interacti...Continue Reading

References

Sep 1, 1978·Journal of Bacteriology·D A Ferguson, C S Cummins
Dec 1, 1977·Journal of Clinical Microbiology·U Hoeffler
Dec 1, 1977·Journal of the National Cancer Institute·C S Cummins, D M Linn
Jan 1, 1978·Applied and Environmental Microbiology·K J McGinleyJ J Leyden
Jun 1, 1978·Applied and Environmental Microbiology·C S GrossC S Cummins
Dec 1, 1978·The Journal of Investigative Dermatology·H L KoG Pulverer
Sep 1, 1976·Antimicrobial Agents and Chemotherapy·U HoefflerG Pulverer
Mar 6, 1975·Nature·C R WoeseD Stahl
Mar 1, 1992·The British Veterinary Journal·I Markowska-DanielG Pulverer
Aug 1, 1991·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·Y OhshimaG Pulverer
Sep 1, 1991·Reviews of Infectious Diseases·I Brook, E H Frazier
Aug 1, 1990·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·J BeuthG Pulverer
Aug 1, 1987·The British Journal of Dermatology·R P AllakerR H Osborne
Aug 1, 1985·The British Journal of Dermatology·R P AllakerJ I Gowers
May 1, 1986·Diagnostic Microbiology and Infectious Disease·W M DunneR J Zabransky
Aug 1, 1974·Journal of Medical Microbiology·R R Marples, K J McGinley
Feb 1, 1973·Applied Microbiology·G Pulverer, H L Ko
Feb 1, 1974·Journal of General Microbiology·C S Cummins, J L Johnson
Jun 1, 1984·Applied and Environmental Microbiology·N K Nordstrom, W C Noble
Jun 1, 1982·The Journal of Hygiene·E Benediktsdóttir, A Hambraeus
Feb 1, 1983·Journal of Clinical Microbiology·P A Nielsen
Oct 8, 1982·JAMA : the Journal of the American Medical Association·R C YocumT R Moench
Jan 1, 1981·Medical Microbiology and Immunology·H L KoG Pulverer
Jan 1, 1980·Chemotherapy·U HöfflerG Pulverer
Nov 1, 1994·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·G PulvererJ Jeljaszewicz
Jan 1, 1995·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H L KoG Pulverer
Dec 7, 1995·European Journal of Pharmacology·M DhouibA A Lugnier
Jul 1, 1996·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·M PottkämperG Pulverer
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R W Armstrong, R D Wuerflein
Feb 1, 1997·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·M KobusG Pulverer
Apr 1, 1997·Canadian Journal of Microbiology·B SteinerR George
Apr 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A VohraJ Barkin
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·M J Jedrzejas

❮ Previous
Next ❯

Citations

Mar 4, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M BrolyS Corvec
May 10, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L Ruffier d'EpenouxS Corvec
Jun 30, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Mehdi Fatahi-Bafghi
Dec 19, 2018·Annales de dermatologie et de vénéréologie·S CorvecB Dréno
Sep 19, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Carlos TorrensStéphane Corvec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Biosynthetic Transformations

Biosyntheic transformtions are multi-step, enzyme-catalyzed processes where substrates are converted into more complex products in living organisms. Simple compounds are modified, converted into other compounds, or joined together to form macromolecules. Discover the latest research on biosynthetic transformations here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Jaime EstebanF Soriano
© 2022 Meta ULC. All rights reserved